Vitamins K1 and K2: The Emerging Group of Vitamins Required for Human Health

Overview

Journal J Nutr Metab

Publisher Wiley

Date 2017 Jul 13

PMID 28698808

Citations 47

Authors

Gerry Kurt Schwalfenberg

Affiliations

Soon will be listed here.

Abstract

Objective: To review the evidence for the use of vitamin K supplementation in clinical conditions such as osteoporosis, vascular calcification, arthritis, cancer, renal calculi, diabetes, and warfarin therapy.

Quality Of Evidence: PubMed was searched for articles on vitamin K (K1 and K2) along with books and conference proceedings and health conditions listed above. Level I and II evidence supports the use of vitamins K1 and K2 in osteoporosis and Level II evidence supports vitamin K2 in prevention of coronary calcification and cardiovascular disease. Evidence is insufficient for use in diabetes, arthritis, renal calculi, and cancer.

Main Message: Vitamin K2 may be a useful adjunct for the treatment of osteoporosis, along with vitamin D and calcium, rivaling bisphosphonate therapy without toxicity. It may also significantly reduce morbidity and mortality in cardiovascular health by reducing vascular calcification. Vitamin K2 appears promising in the areas of diabetes, cancer, and osteoarthritis. Vitamin K use in warfarin therapy is safe and may improve INR control, although a dosage adjustment is required.

Conclusion: Vitamin K supplementation may be useful for a number of chronic conditions that are afflicting North Americans as the population ages. Supplementation may be required for bone and cardiovascular health.

Citing Articles

Mechanisms and Potential Benefits of Neuroprotective Agents in Neurological Health.

Pekdemir B, Raposo A, Saraiva A, Lima M, Alsharari Z, BinMowyna M Nutrients. 2025; 16(24.

PMID: 39770989 PMC: 11677798. DOI: 10.3390/nu16244368.

Exploring the potential of soapstock over a glycerol in vitamin K2 production by Bacillus subtilis natto: a comparative analysis.

Ansari F, Nouri H, Moghimi H Microb Cell Fact. 2024; 23(1):348.

PMID: 39731131 PMC: 11681655. DOI: 10.1186/s12934-024-02629-1.

Circulating Phylloquinone and the Risk of Four Female-Specific Cancers: A Mendelian Randomization Study.

Yalew M, Mulugeta A, Lumsden A, Madakkatel I, Lee S, Oehler M Nutrients. 2024; 16(21).

PMID: 39519513 PMC: 11547380. DOI: 10.3390/nu16213680.

Nutrient Analysis of Raw United States Beef Offal Items.

Fuerniss H, Gifford C, Mortensen E, Belk K, Engle T, Woerner D Nutrients. 2024; 16(18).

PMID: 39339704 PMC: 11435426. DOI: 10.3390/nu16183104.

The investigation of connection between anticoagulant therapy and vitamin K homologues in human determined by LC-MS/MS.

Qi X, Chen N, Song Q, Chu Y, Wu H, Shan J Bioanalysis. 2024; 16(17-18):973-984.

PMID: 39140688 PMC: 11485696. DOI: 10.1080/17576180.2024.2383109.

References

Tagalakis V, Tamim H, Blostein M, Hanley J, Kahn S . Risk of prostate cancer death in long-term users of warfarin: a population-based case-control study. Cancer Causes Control. 2013; 24(6):1079-85. DOI: 10.1007/s10552-013-0185-1. View

Knapen M, Drummen N, Smit E, Vermeer C, Theuwissen E . Three-year low-dose menaquinone-7 supplementation helps decrease bone loss in healthy postmenopausal women. Osteoporos Int. 2013; 24(9):2499-507. DOI: 10.1007/s00198-013-2325-6. View

Fusaro M, Tripepi G, Noale M, Plebani M, Zaninotto M, Piccoli A . Prevalence of vertebral fractures, vascular calcifications, and mortality in warfarin treated hemodialysis patients. Curr Vasc Pharmacol. 2013; 13(2):248-58. DOI: 10.2174/15701611113119990146. View

Yoshida T, Miyazawa K, Kasuga I, Yokoyama T, Minemura K, Ustumi K . Apoptosis induction of vitamin K2 in lung carcinoma cell lines: the possibility of vitamin K2 therapy for lung cancer. Int J Oncol. 2003; 23(3):627-32. View

Abdel-Rahman M, Alkady E, Ahmed S . Menaquinone-7 as a novel pharmacological therapy in the treatment of rheumatoid arthritis: A clinical study. Eur J Pharmacol. 2015; 761:273-8. DOI: 10.1016/j.ejphar.2015.06.014. View

Shea M, Booth S, Miller M, Burke G, Chen H, Cushman M . Association between circulating vitamin K1 and coronary calcium progression in community-dwelling adults: the Multi-Ethnic Study of Atherosclerosis. Am J Clin Nutr. 2013; 98(1):197-208. PMC: 3683819. DOI: 10.3945/ajcn.112.056101. View

Misra D, Booth S, Tolstykh I, Felson D, Nevitt M, Lewis C . Vitamin K deficiency is associated with incident knee osteoarthritis. Am J Med. 2013; 126(3):243-8. PMC: 3641753. DOI: 10.1016/j.amjmed.2012.10.011. View

Annweiler C, Ferland G, Barberger-Gateau P, Brangier A, Rolland Y, Beauchet O . Vitamin K antagonists and cognitive impairment: results from a cross-sectional pilot study among geriatric patients. J Gerontol A Biol Sci Med Sci. 2014; 70(1):97-101. DOI: 10.1093/gerona/glu133. View

Je S, Joo N, Choi B, Kim K, Kim B, Park S . Vitamin K supplement along with vitamin D and calcium reduced serum concentration of undercarboxylated osteocalcin while increasing bone mineral density in Korean postmenopausal women over sixty-years-old. J Korean Med Sci. 2011; 26(8):1093-8. PMC: 3154347. DOI: 10.3346/jkms.2011.26.8.1093. View

10.

Yamaguchi M . Regulatory mechanism of food factors in bone metabolism and prevention of osteoporosis. Yakugaku Zasshi. 2006; 126(11):1117-37. DOI: 10.1248/yakushi.126.1117. View

11.

Pearson D . Bone health and osteoporosis: the role of vitamin K and potential antagonism by anticoagulants. Nutr Clin Pract. 2007; 22(5):517-44. DOI: 10.1177/0115426507022005517. View

12.

Unden G, Bongaerts J . Alternative respiratory pathways of Escherichia coli: energetics and transcriptional regulation in response to electron acceptors. Biochim Biophys Acta. 1997; 1320(3):217-34. DOI: 10.1016/s0005-2728(97)00034-0. View

13.

Neogi T, Booth S, Zhang Y, Jacques P, Terkeltaub R, Aliabadi P . Low vitamin K status is associated with osteoarthritis in the hand and knee. Arthritis Rheum. 2006; 54(4):1255-61. DOI: 10.1002/art.21735. View

14.

Schurgers L, Teunissen K, Hamulyak K, Knapen M, Vik H, Vermeer C . Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2006; 109(8):3279-83. DOI: 10.1182/blood-2006-08-040709. View

15.

Cockayne S, Adamson J, Lanham-New S, Shearer M, Gilbody S, Torgerson D . Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006; 166(12):1256-61. DOI: 10.1001/archinte.166.12.1256. View

16.

Leblanc C, Presse N, Lalonde G, Dumas S, Ferland G . Higher vitamin K intake is associated with better INR control and a decreased need for INR tests in long-term warfarin therapy. Thromb Res. 2014; 134(1):210-2. DOI: 10.1016/j.thromres.2014.04.024. View

17.

Sconce E, Avery P, Wynne H, Kamali F . Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2006; 109(6):2419-23. DOI: 10.1182/blood-2006-09-049262. View

18.

Chen J, Liu J, Zhang Y, Ye Z, Wang S . Decreased renal vitamin K-dependent gamma-glutamyl carboxylase activity in calcium oxalate calculi patients. Chin Med J (Engl). 2003; 116(4):569-72. View

19.

Allison A . The possible role of vitamin K deficiency in the pathogenesis of Alzheimer's disease and in augmenting brain damage associated with cardiovascular disease. Med Hypotheses. 2001; 57(2):151-5. DOI: 10.1054/mehy.2001.1307. View

20.

Hamidi M, Cheung A . Vitamin K and musculoskeletal health in postmenopausal women. Mol Nutr Food Res. 2014; 58(8):1647-57. DOI: 10.1002/mnfr.201300950. View